Latest Earnings Results: Q2 '26
Estimated EPS
$0.32
Reported EPS
$0.50
Surprise
+55.25%
Estimated Rev
$7.51B
Reported Rev
$7.68B
Surprise
+2.32%
• Reported GAAP EPS of $0.07 • Reported revenue of $7.68B up 11.60% YoY • Medline is updating its full year 2026 outlook for Organic Sales growth to 9.0% to 10.0% and expects Adjusted EBITDA to be between $3.3 billion and $3.4 billion for 2026.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | $0.35 | -- | -- | N/A |
Q2 '26 | $0.32 | $0.50 | 55.25% | BEAT |
Q1 '26 | $0.30 | $0.33 | 11.81% | BEAT |
Q4 '25 | $0.24 | $0.22 | -5.60% | MISSED |